113 related articles for article (PubMed ID: 2757844)
1. [Clinical significance of sialic acid in the CSF; in relation to the malignancy and leptomeningeal dissemination].
Moroki K; Kuratsu J; Yoshioka S; Kohchi M; Uemura S; Matsukado Y; Ushio Y
No To Shinkei; 1989 Mar; 41(3):305-7. PubMed ID: 2757844
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of neuron specific enolase (NSE) in the cerebrospinal fluid of malignant brain tumor with intrathecal metastasis].
Miyagami M; Tazoe M; Tsubokawa T
No To Shinkei; 1989 Oct; 41(10):1021-7. PubMed ID: 2605041
[TBL] [Abstract][Full Text] [Related]
3. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].
Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal dissemination of primary central nervous system tumors of childhood.
Packer RJ; Siegel KR; Sutton LN; Litmann P; Bruce DA; Schut L
Ann Neurol; 1985 Aug; 18(2):217-21. PubMed ID: 4037762
[TBL] [Abstract][Full Text] [Related]
5. CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases.
Reijneveld JC; Brandsma D; Boogerd W; Bonfrer JG; Kalmijn S; Voest EE; Geurts-Moespot A; Visser MC; Taphoorn MJ
Neurology; 2005 Oct; 65(7):1120-2. PubMed ID: 16217072
[TBL] [Abstract][Full Text] [Related]
6. Detection of malignant cells in cerebrospinal fluid using fluorescence in situ hybridization.
van Oostenbrugge RJ; Hopman AH; Lenders MH; van Heerde P; Arends JW; Ramaekers FC; Twijnstra A
J Neuropathol Exp Neurol; 1997 Jun; 56(6):743-8. PubMed ID: 9184665
[TBL] [Abstract][Full Text] [Related]
7. [Diffuse metastatic leptomeningeal carcinomatosis (DMLC)].
Ishikura A; Hunaki N
Gan No Rinsho; 1987 Jul; 33(8):881-4. PubMed ID: 3613110
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-8 CSF levels predict survival in patients with leptomeningeal metastases.
Brandsma D; Taphoorn MJ; de Jager W; Bonfrer H; Algra A; Reijneveld JC; Boogerd W; Korse T; Verbeek MM; Rijkers GT; Voest EE
Neurology; 2006 Jan; 66(2):243-6. PubMed ID: 16434663
[TBL] [Abstract][Full Text] [Related]
9. Total and lipid-bound sialic acid in the cerebrospinal fluid of patients with brain tumors.
Kakari S; Avgoustatos G; Ferderigos AS; Poulaki E; Sakka P; Karamplianis A; Konstadinidis E; Constantopoulos G
Anticancer Res; 1984; 4(4-5):313-6. PubMed ID: 6486735
[TBL] [Abstract][Full Text] [Related]
10. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic efficiency of serum lipid-bound sialic acid level in malignant pleural effusions].
Bektemür G; Ozer F; Kanat F; Imecik O
Tuberk Toraks; 2003; 51(3):265-70. PubMed ID: 15143404
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid biochemical markers of central nervous system metastases.
Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
[TBL] [Abstract][Full Text] [Related]
13. Leptomeningeal carcinomatosis.
Grossman SA; Krabak MJ
Cancer Treat Rev; 1999 Apr; 25(2):103-19. PubMed ID: 10395835
[TBL] [Abstract][Full Text] [Related]
14. D-dimer levels in the cerebrospinal fluid: a marker of central nervous system involvement in neoplastic disease.
Eclache V; Vu T; Le Roux G
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):321-4. PubMed ID: 7971253
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal metastases in malignant childhood astrocytomas.
Kandt RS; Shinnar S; D'Souza BJ; Singer HS; Wharam MD; Gupta PK
J Neurooncol; 1984; 2(2):123-8. PubMed ID: 6090601
[TBL] [Abstract][Full Text] [Related]
16. [Ferritin in the cerebrospinal fluid as an early indicator of neuromeningeal involvement in patients with malignant lymphoma].
Aviles A; Gómez R; Salas J
Gac Med Mex; 1991; 127(3):249-52. PubMed ID: 1800218
[TBL] [Abstract][Full Text] [Related]
17. [Myelin basic protein in the cerebrospinal fluid of patients with neurological disease: especially with malignant brain tumors].
Nakagawa H; Fujita T; Tsuruzono K; Kubo S; Yamada M; Miyawaki Y; Tokiyoshi K; Kanayama T; Hasegawa H; Koshino K
No Shinkei Geka; 1994 Feb; 22(2):111-8. PubMed ID: 7509461
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
Kosmas C; Tsavaris NB; Tsakonas G; Soukouli G; Gassiamis A; Mylonakis N; Karabelis A
Med Sci Monit; 2005 Aug; 11(8):CR398-401. PubMed ID: 16049383
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies.
van den Bent MJ; Lamers CH; van 't Veer MB; Sillevis Smitt PA; Bolhuis RL; Gratama JW
Ann Hematol; 2002 Apr; 81(4):187-91. PubMed ID: 11976819
[TBL] [Abstract][Full Text] [Related]
20. [Cerebrospinal fluid cytology in meningeal invasion of leukemia and malignant lymphoma. Reliable diagnosis by immunocytochemistry].
Bamborschke S; Huber M
Nervenarzt; 1992 Apr; 63(4):218-22. PubMed ID: 1594087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
